Efficacy of Gene Therapy SB-525 Now at 14 Months in Alta Hemophilia A Trial

Efficacy of Gene Therapy SB-525 Now at 14 Months in Alta Hemophilia A Trial

Hemophilia News Today

Image

Please enable the javascript to submit this form

Supported by educational grants from Bayer, BioMarin, Freeline Therapeutics Limited, Pfizer Inc., Shire, Spark Therapeutics, and uniQure, Inc.

Essential SSL